Influence of fluoroquinolones on viability of Balb/c 3T3 and HepG2 cells
By: Lidia Radko, Maria Minta and Sylwia Stypuła-Trębas
Open Access
|Dec 2013References
- 1. Ayaki M., Iwasawa A., Niwano Y.:assessment of the cytotoxicity of six topical antibiotics to four cultured ocular surface cell lines. Biocontrol Sci 2012, 17, 93-99.
- 2. Bertino J., Fish D.: The safety profile of the fluoroquinolones. Clin Ther 2000, 22,798-817.
- 3. Borenfreund E., Puerner J.A.: Toxicity determinedby morphological alterations and neutral red absorption. Toxicol Lett 1985, 24, 119-124.
- 4. Bradford M.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of dye binding. Anal Biochem 1976, 72, 248-254.
- 5. Durso L.M., Miller D.N., Wienhold B.J.: Distribution and quantification of antibiotic resistant genes and bacteria across agricultural and non-agricultural metagenomes. PLoS One 2012, 7, 1-12.
- 6. Ferreira M.B., Myiagi S., Nogales C.G., Campos M.S., Lage - Marques J.L.: Time-and concentration-dependent cytotoxicity of antibiotics used in endodontic therapy. J Appl Oral Sci 2010, 18, 259-263.
- 7. Fotakis G., Timbrell J.A.:cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 2006, 160, 171-177.
- 8. Garcia-Kaufer M., Haddad T., Bergheim M., Gminski R., Gupta P., Mathur N., Kummerer K., Mersch-Sundermann V.: Genotoxic effect of ciprofloxacin during photolytic decomposition monitored by themicronucleus test (MNvit) in HepG2 cells. Environ Sci Pollut Res 2012, 19, 1719-1727.
- 9. Hernandez-Arteseros J.A., Barbosa J., Compaňo R., Prat M.D.: Analysis of quinolone residues in edible animal products. J Chromatogr A 2002, 945, 1-24.
- 10. Herold C., Ocker M., Ganslmayer M., Hahn E.G., Schuppan D.: Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer 2002, 86, 443-448.
- 11. Hincal F., Gurbay A., Favier A.: Biphasic response of ciprofloxacin in human fibroblast cell cultures. Nonlinearity Biol Toxicol Med 2003, 1, 481-492.
- 12. Holtom P.D., Pavkovic S.A., Bravos P.D., Patzakis M.J., Shepherd L.E., Frenkel B.: Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells. J Orthop Res 1999, 18, 721-727.
- 13. Iwasawa A., Ayaki M., Niwano Y.: Cell viability score (CVS) as a good indicator of critical concentration of benzalkonium chloride for toxicity in cultured ocular surface cell lines. Regul Toxicol Pharmacol 2013, 66, 177-183.
- 14. Kamat A., Lamm D.L.: Antitumor activity of common antibiotics against superficial bladder cancer. Urology 2004, 63, 457-460.
- 15. Kloskowski T., Gurtowska N., Nowak M., Joachimiak R., Bajek A., Olkowska J., Drewa T.: The influence of ciprofloxacin on viability of A549, HepG2, A375.S2, B16 and C6 cell lines. Acta Pol Pharm 2011, 68, 859-865.
- 16. Korzeniewski C., Calleawert D.M.: An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983, 64, 313-320.
- 17. Kruse M., Kilic B., Flik B., Stahlmann R.: Effect of quinupristin/dalfopristin on 3T3 and Eahy926 cellsin comparison to other antimicrobial agents with the potential to induce infusion phlebitis. Arch Toxicol 2007, 81, 447-452.
- 18. Licata A., Randazzo C., Morreale I., Butera G., D`Alessandro N., Craxi A.: Fluoroquinolone-induced liver injury: three new cases and a review of the literature. Eur J Clin Pharmacol 2012, 68, 525-532.
- 19. Liguori M.J., Blomme E.A.G., Waring J.F.: Trovafloxacin- induced gene expression changes in liver-derivedsystems: comparison of primary human hepatocytes to HepG2. Drug Metab Dispos 2008, 36, 223-233.
- 20. Martinez M., McDermott R., Walker R.: Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet J 2006, 172, 10-28.
- 21. Mestorino N., Marchetti M.L., Turic E., Pesoa J., Errecalde J.: Concentrations of danofloxacin 18% solution in plasma, milk and tissues after subcutaneous injection in dairy cows. Anal Chim Acta 2009, 637, 33-39.
- 22. Minta M., Wilk I., Żmudzki J.: Inhibition of cell differentation by quinolones in micromass cultures of rat embryonic limb bud and midbrain cells. Toxicol in Vitro 2005, 19, 915-919.
- 23. Miolo G., Viola G., Vedaldi D., Dall`Acqua F., Fravolini A., Tabarrini O., Cecchetti V.:photocytotoxic properties of new 6-desfluoro and 6-fluoro-8-methylquinolones. Toxicol in Vitro 2002, 16, 683-693.
- 24. Mosmann T.: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 1983, 65, 55-63.
- 25. Scheers E.M., Ekwall B., Dierickx P.J.:long-term cytotoxicity testing of 27 MEIC chemicals on HepG2 cells and comparison with acute human toxicity data. Toxicol in Vitro 2001, 15, 153-161.
- 26. Sukul P., Spiteller M.: Fluoroquinolone antibiotics in the environment. Rev Environ Contam Toxicol 2007, 191, 131-162.
- 27. Weyermenn J., Lohmann D., Zimmer A.: A practical note on the use of cytotoxicity assays. Int J Pharm 2005, 288, 369-376.
DOI: https://doi.org/10.2478/bvip-2013-0102 | Journal eISSN: 2450-8608 (formerly 2300-3235)
Language: English
Page range: 599 - 606
Published on: Dec 31, 2013
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2013 Lidia Radko, Maria Minta, Sylwia Stypuła-Trębas, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons License.